KemPharm, Inc. announced the appointment of Richard Pascoe, CEO of Apricus Biosciences, and Joseph B. Saluri, Vice-President - General Counsel, Stine Seed Company, to the company's Board of Directors. The additions of Mr. Pascoe and Mr. Saluri bring extensive public company and business development experience to KemPharm as the company prepares for multiple clinical and business milestones in 2014.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.475 USD | -0.99% | +16.28% | -0.23% |
07-01 | Zevra Therapeutics, Inc.(NasdaqGS:ZVRA) added to Russell 3000 Growth Index | CI |
07-01 | Zevra Therapeutics, Inc.(NasdaqGS:ZVRA) added to Russell Microcap Growth Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.23% | 274M | |
+34.09% | 10.31B | |
+40.84% | 5.23B | |
-18.53% | 4.62B | |
+12.65% | 3.52B | |
+27.58% | 2.31B | |
-39.96% | 1.78B | |
-45.87% | 1.69B | |
-0.50% | 1.64B | |
+1.12% | 1.59B |
- Stock Market
- Equities
- ZVRA Stock
- News Zevra Therapeutics, Inc.
- KemPharm, Inc. Announces Board Appointments